Risperdal Lawsuits For Breast Growth in Boys

Risperdal Side Effects

Home
Risperdal Side Effects
×

FREE LAWSUIT REVIEW

Fill out this form now to find out if you are entitled to compensation. This consultation is fast, free confidential and you don’t need to hire the attorney you speak with.

Risperdal Side Effects

There are serious side effects associated with Risperdal including gynecomastia. You may be entitled to compensation if you or a loved one is experiencing abnormal breast growth from Risperdal. Talk to an attorney today by filling out the form.

Despite the fact that Johnson & Johnson’s Risperdal (risperidone) is one of the most widely used antipsychotic drugs on the market, there are a number of side effects allegedly associated with the medication that have raised serious concerns among healthcare providers and drug regulators. Among the side effects possibly linked to Risperdal is a condition called gynecomastia, characterized by abnormal breast growth in boys and young men, and the potential association between Risperdal and gynecomastia has been evident since 1999, when researchers found breast growth side effects in patients taking Risperdal with the antidepressant Prozac. Since that time, more and more patients taking the antipsychotic drug have reported gynecomastia and other life-altering side effects, and J&J now faces at least 420 lawsuits filed on behalf of affected Risperdal users.

Side Effects Potentially Linked to Risperdal

Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1993 as a treatment for schizophrenia, although the agency later indicated the medication to treat additional psychiatric disorders, including bipolar disorder and acute mania associated with autistic disorders. According to national statistics on prescription drug use, during the 12 months ending in October 2011, more than 54 million prescriptions were filled for antipsychotic drugs, and Risperdal accounted for nearly one-quarter of those prescriptions. Unfortunately, mounting research suggests that patients who took Risperdal may have been exposed to devastating side effects, including:

  • Hyperglycemia
  • Risperdal diabetes
  • Hyperosmolar Coma
  • Heart attack
  • Tardive Dyskinesia
  • Stroke
  • Gynecomastia (Male Breast Growth)

Connection Between Risperdal and Side Effects

Information about the risk of side effects with Risperdal use is not new. Back in 1999, the medical journal Psychopharmacology published a study in which researchers linked Risperdal to male breast growth complications when taken with the antidepressant Prozac. In 2006, the Journal of Clinical Psychopharmacology published additional research indicating that levels of the prolactin hormone can increase significantly when Risperdal is administered to adolescents, elevating the risk of gynecomastia side effects in those patients. In yet another study published in the Journal of Child and Adolescent Psychopharmacology in 2009, study authors found that prolactin levels associated with use of the antipsychotic drug remained elevated for up to two years. In total, there have been as many as 34 Risperdal studies from six countries, indicating side effects ranging from diabetes and high blood sugar to stroke and sudden cardiac death.

Adverse Effects of Dangerous Medications

Most consumers recognize the fact that no medication is 100% safe, but few truly understand how devastating pharmaceutical drug-related side effects can be for victims and their families. Even so, when drug companies are straightforward about the risks of medication side effects, at least consumers can make educated decisions about which pharmaceutical drugs are safe for them to take and which are associated with risks that are far too great to be worth it. When drug manufacturing companies intentionally conceal side effect information, however, patients are robbed of their right to make this important decision. Not only has Johnson & Johnson been accused of failure to warn consumers about the side effect risks associated with Risperdal, but the company is also suspected of illegally marketing its antipsychotic drug for off-label uses unapproved by the FDA, putting millions of patients nationwide at unnecessary risk of injury and fatality.

Copyright 2013 Risperdal Law